We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+9.81%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$79.2B
AUM Growth
+$3.07B
(+4%)
Cap. Flow
-$2.3B
Cap. Flow
% of AUM
-2.9%
Top 10 Holdings %
Top 10 Hldgs %
48.93%
Holding
809
New
117
Increased
205
Reduced
335
Closed
91
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$331M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$327M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$319M |
| 4 |
Allison Transmission
ALSN
|
+$195M |
| 5 |
BA.PRA
Boeing Co 6.00% Series A Preferred Stock
BA.PRA
|
+$50M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$853M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$294M |
| 3 |
NVIDIA
NVDA
|
+$266M |
| 4 |
Netflix
NFLX
|
+$190M |
| 5 |
Meta Platforms (Facebook)
META
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.48% |
| 2 | Consumer Discretionary | 18.83% |
| 3 | Communication Services | 18.1% |
| 4 | Healthcare | 11.79% |
| 5 | Financials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Antero Resources
AR
$11.2B
| $23.7M | 0.03% |
675,490
+188,729
| +39% | +$5.71M |
|
227
Flowserve
FLS
$10.1B
| $23.6M | 0.03% |
+410,541
| New | +$23.6M |
|
228
Guidewire Software
GWRE
$14.5B
| $23.1M | 0.03% |
136,990
+20,173
| +17% | +$3.77M |
|
229
Apple
AAPL
$4.48T
| $22.9M | 0.03% |
91,534
-3,572
| -4% | -$842K |
|
230
Agree Realty
ADC
$9.24B
| $22.8M | 0.03% |
323,852
+5,021
| +2% | +$374K |
|
231
Crane NXT
CXT
$2.95B
| $22.4M | 0.03% |
384,487
+7,399
| +2% | +$425K |
|
232
Parsons
PSN
$4.93B
| $21.4M | 0.03% |
231,475
-77,411
| -25% | -$7.89M |
|
233
Power Integrations
POWI
$3.46B
| $21.2M | 0.03% |
344,063
-10,743
| -3% | -$683K |
|
234
Baidu
BIDU
$37B
| $21.2M | 0.03% |
251,344
-6,237
| -2% | -$569K |
|
|
PLGO
235
Pelagos Insurance Capital
PLGO
$2.12B
| $21.1M | 0.03% |
1,166,264
+510,699
| +78% | +$9.48M |
|
236
ESAB
ESAB
$5.33B
| $21M | 0.03% |
+175,477
| New | +$21.2M |
|
237
Tidewater
TDW
$4.3B
| $21M | 0.03% |
383,887
-34,943
| -8% | -$1.99M |
|
238
Jazz Pharmaceuticals
JAZZ
$16.6B
| $20.9M | 0.03% |
169,621
+62,969
| +59% | +$7.42M |
|
239
Boston Beer
SAM
$1.88B
| $20.6M | 0.03% |
68,699
-4,134
| -6% | -$1.25M |
|
240
Pinnacle Financial Partners Inc
PNFP
$15.7B
| $20.6M | 0.03% |
180,122
-2,665
| -1% | -$301K |
|
241
Wave Life Sciences
WVE
$1.2B
| $20.5M | 0.03% |
+1,660,866
| New | +$22.2M |
|
242
Cavco Industries
CVCO
$4.5B
| $20.4M | 0.03% |
+45,677
| New | +$21M |
|
243
Performance Food Group
PFGC
$18B
| $20.2M | 0.03% |
239,368
-7,409
| -3% | -$625K |
|
244
APi Group
APG
$18.2B
| $20M | 0.03% |
832,529
+28,839
| +4% | +$686K |
|
245
Vanguard Morningstar Growth ETF
VUG
$230B
| $20M | 0.03% |
291,750
+204,180
| +233% | +$13.7M |
|
246
Eagle Materials
EXP
$6.44B
| $19.9M | 0.03% |
80,782
-1,187
| -1% | -$343K |
|
247
iShares Broad USD High Yield Corporate Bond ETF
USHY
$29.1B
| $19.8M | 0.03% |
539,185
+94,712
| +21% | +$3.52M |
|
248
Loar Holdings
LOAR
$6.64B
| $19.7M | 0.02% |
267,013
-8,487
| -3% | -$696K |
|
249
Concentrix
CNXC
$1.55B
| $19.6M | 0.02% |
453,773
+148,281
| +49% | +$6.59M |
|
250
Veeco
VECO
$3.06B
| $19.6M | 0.02% |
729,683
-21,320
| -3% | -$619K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q4 2024 Portfolio in Review
As of Q4 2024, Loomis, Sayles & Company held 809 positions worth $79.2B, up 4% from $76.2B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Loomis, Sayles & Company's Q4 2024 filing shows 117 new, 205 increased, 335 reduced and 91 closed positions. Its largest new stake was Boeing Co 6.00% Series A Preferred Stock: 886,790 shares worth $157M. The largest sale was Tesla, an estimated $853M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Loomis, Sayles & Company's largest Q4 2024 buy was Boeing Co 6.00% Series A Preferred Stock: 886,790 shares worth $157M.
- Loomis, Sayles & Company added most to Regeneron Pharmaceuticals in Q4 2024, an estimated $331M increase.
- Loomis, Sayles & Company's biggest Q4 2024 reduction was Tesla, cutting an estimated $853M.
- Loomis, Sayles & Company fully exited Medpace in Q4 2024, selling an estimated $68.7M.
- Loomis, Sayles & Company's ten largest holdings make up 49% of its $79.2B portfolio in Q4 2024.
- Loomis, Sayles & Company opened 117 new positions and closed 91 in Q4 2024.
- Loomis, Sayles & Company's portfolio value rose 4% quarter-over-quarter to $79.2B.
Based on Loomis, Sayles & Company's 13F filing for Q4 2024, filed 12 Feb 2025.